CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Planned sale EVP and Chief Legal Officer sold 9,806 shares at $45.00 ($441,270)
- 4 Planned sale Director sold 1,737 shares at $41.10 ($71,391)
- 4 Open-market sale EVP and Chief Medical Officer sold 354 shares at $43.66 ($15,456)
- 4 Open-market sale EVP and Chief Medical Officer sold 142 shares at $44.10 ($6,262)
- 4 Shares withheld for taxes SVP, Chief Accounting Officer gave up 14 shares (to pay taxes)
- 4 Open-market sale CBO & EVP sold 11,509 shares at $49.93 ($574,644)
- 4 Planned sale Director sold 12,195 shares at an average $50.88 ($620,443)
- 4 Grant or award Chief Financial Officer acquired 19,400 shares (grant or award)
- 4 Open-market sale EVP and Chief Legal Officer sold 3,756 shares at $53.76 ($201,923)
- 4 Open-market sale CBO & EVP sold 1,011 shares at $53.76 ($54,351)
- 4 Shares withheld for taxes Huang Dennis Karl gave up 470 shares (to pay taxes)
- 4 Open-market sale Pinion John Richard sold 4,173 shares at $53.76 ($224,340)
- 4 Open-market sale SVP, Chief Accounting Officer sold 341 shares at $53.76 ($18,332)
- 4 Open-market sale EVP and Chief Medical Officer sold 1,238 shares at $53.76 ($66,555)
- 4 Open-market sale EVP & Chief Commercial Officer sold 4,768 shares at $53.76 ($256,328)
- 4 Shares withheld for taxes President & CEO gave up 17,417 shares (to pay taxes)
- 4 Open-market sale President & CEO sold 30,000 shares at $45.00 ($1,350,000)
- 4 Open-market sale President & CEO sold 30,000 shares at $47.87 ($1,436,100)
- 4 Exercise or conversion SVP, Chief Accounting Officer acquired 3,000 shares (option exercise)
- 4 Planned sale CBO & EVP sold 39,878 shares at $32.78 ($1,307,201)
Page 5 of 32 · 627 filings